Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
ChemicalBook >   Product Catalog >  Biochemical Engineering >  Inhibitors

Inhibitors

Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
More
Less

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information

Structure:
Chemical Name:
Elamipretide
CAS:
736992-21-5
MF:
C32H49N9O5
Structure:
Chemical Name:
(Z,Z)-7,11-Hexadecadienal
CAS:
96883-54-4
MF:
C16H28O
Structure:
Chemical Name:
Ginsenoside CK
CAS:
39262-14-1
MF:
C36H62O8
Structure:
Chemical Name:
BIBF-1120
CAS:
928326-83-4
MF:
C31H33N5O4
Structure:
Chemical Name:
MRTX1133
CAS:
2621928-55-8
MF:
C33H31F3N6O2
Structure:
Chemical Name:
N-(3-(5-(2-cyclopropylpyrimidin-5-yl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,6-difluorophenyl)propane-1-sulfonamide
CAS:
2409140-12-9
MF:
C24H21F2N5O3S
Chemical Name:
Retatrutide
CAS:
2381089-83-2
Chemical Name:
GSK3685032
Structure:
Chemical Name:
Exatecan
CAS:
171335-80-1
MF:
C24H22FN3O4
Structure:
Chemical Name:
4H-Pyrazolo[1,5-a][1,4]diazepine-2-carboxamide, 5-[(7S)-7-[3-amino-2-fluoro-5-(1-propyn-1-yl)-6-(trifluoromethyl)phenyl]-7,8-dihydro-2-[[(7aS)-tetrahydro-2-methylene-1H-pyrrolizin-7a(5H)-yl]methoxy]-5H-pyrano[4,3-d]pyrimidin-4-yl]-3-chloro-5,6,7,8-tetrahydro-N,N-dimethyl-
CAS:
3024878-19-8
MF:
C36H39ClF4N8O3
Structure:
Chemical Name:
hGH 176-191
CAS:
66004-57-7
MF:
C78H123N23O22S2
Chemical Name:
Slidenafil
Structure:
Chemical Name:
DIPENTAERYTHRITOL HEXAKIS(3-MERCAPTOPROPIONATE)
CAS:
25359-71-1
MF:
C28H46O13S6
Chemical Name:
Dexmedetomidine
MF:
C13H16N2
Structure:
Chemical Name:
ERK1/2 inhibitor 1
CAS:
2095719-90-5
MF:
C29H32ClN5O4
Chemical Name:
PE 22-28
Structure:
Chemical Name:
Kisspeptin 10 (human)
CAS:
374675-21-5
MF:
C63H83N17O14
Structure:
Chemical Name:
Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid
CAS:
486460-00-8
MF:
C15H18F3NO4
Structure:
Chemical Name:
Abemaciclib
CAS:
1231929-97-7
MF:
C27H32F2N8
Structure:
Chemical Name:
LasMiditan
CAS:
439239-90-4
MF:
C19H18F3N3O2
Structure:
Chemical Name:
Mitapivat
CAS:
1260075-17-9
MF:
C24H26N4O3S
Structure:
Chemical Name:
Lemborexant
CAS:
1369764-02-2
MF:
C22H20F2N4O2
Structure:
Chemical Name:
yk11
CAS:
1370003-76-1
MF:
C25H34O6
Structure:
Chemical Name:
3,4-Methylenedioxy-N-benzylcathinone (hydrochloride)
CAS:
1823274-68-5
MF:
C17H18ClNO3
Structure:
Chemical Name:
DSM265
CAS:
1282041-94-4
MF:
C14H12F7N5S
Structure:
Chemical Name:
Teneligliptin Hydrobromide Hydrate
CAS:
1572583-29-9
MF:
C22H33BrN6O2S
Structure:
Chemical Name:
Eptifibatide Acetate
CAS:
148031-34-9
MF:
C35H49N11O9S2
Structure:
Chemical Name:
PRN-1008
CAS:
1575591-66-0
MF:
C36H40FN9O3
Structure:
Chemical Name:
(Z)-hexadec-9-enal
CAS:
56219-04-6
MF:
C16H30O
Structure:
Chemical Name:
Belzutifan
CAS:
1672668-24-4
MF:
C17H12F3NO4S
Structure:
Chemical Name:
Mobocertinib succinate
CAS:
2389149-74-8
MF:
C36H45N7O8
Structure:
Chemical Name:
Metonitazene
CAS:
14680-51-4
MF:
C21H26N4O3
Structure:
Chemical Name:
Narmafotinib
CAS:
1393653-34-3
MF:
C28H32F3N5O2
Structure:
Chemical Name:
ALC-0315
CAS:
2036272-55-4
MF:
C48H95NO5
Structure:
Chemical Name:
2-benzyl-1H-benzimidazole monohydrochloride
CAS:
1212-48-2
MF:
C14H13ClN2
Chemical Name:
Ulinastatin
CAS:
80449-31-6
MF:
C13H16O3
Structure:
Chemical Name:
5-[(4-dimethylamino-3,5-dimethoxy-phenyl)methyl]pyrimidine-2,4-diamine
CAS:
56066-63-8
MF:
C15H21N5O2
Structure:
Chemical Name:
Binodenoson
CAS:
144348-08-3
MF:
C17H25N7O4
Chemical Name:
SLU-PP-322
Structure:
Chemical Name:
CALYCULIN A
CAS:
101932-71-2
MF:
C50H81N4O15P
Structure:
Chemical Name:
Z-8-DODECEN-1-OL
CAS:
40642-40-8
MF:
C12H24O
Structure:
Chemical Name:
Indacaterol
CAS:
312753-06-3
MF:
C24H28N2O3
Structure:
Chemical Name:
Relebactam
CAS:
1174018-99-5
MF:
C12H20N4O6S
Structure:
Chemical Name:
Lurbinectedin
CAS:
497871-47-3
MF:
C41H44N4O10S
Structure:
Chemical Name:
JTC-801
CAS:
244218-93-7
MF:
C26H25N3O2
Structure:
Chemical Name:
Gilteritinib
CAS:
1254053-43-4
MF:
C29H44N8O3
Structure:
Chemical Name:
BLU9931
CAS:
1538604-68-0
MF:
C26H22Cl2N4O3
Structure:
Chemical Name:
Oclacitinib maleate
CAS:
1640292-55-2
MF:
C19H27N5O6S
Structure:
Chemical Name:
Tafenoquine Succinate
CAS:
178429-62-4
MF:
C10H14N2O2
Structure:
Chemical Name:
Tenapanor hydrochloride
CAS:
1234365-97-9
MF:
C50H68Cl6N8O10S2
Structure:
Chemical Name:
CMLD-2
CAS:
958843-91-9
MF:
C31H31NO6
Structure:
Chemical Name:
CASPASE INHIBITOR I, BIOTIN CONJUGATE
CAS:
1135688-15-1
MF:
C30H49FN6O8S
Structure:
Chemical Name:
Evocalcet
CAS:
870964-67-3
MF:
C24H26N2O2
Structure:
Chemical Name:
Lazertinib
CAS:
1903008-80-9
MF:
C30H34N8O3
Structure:
Chemical Name:
Cariprazine hydrochloride
CAS:
1083076-69-0
MF:
C21H33Cl3N4O
Structure:
Chemical Name:
GRT6005
CAS:
863513-91-1
MF:
C24H27FN2O
Structure:
Chemical Name:
AZD 3759
CAS:
1626387-80-1
MF:
C22H23ClFN5O3
Structure:
Chemical Name:
DASA-58
CAS:
1203494-49-8
MF:
C19H23N3O6S2
Structure:
Chemical Name:
Ulixertinib hydrochloride
CAS:
1956366-10-1
MF:
C21H23Cl3N4O2
Structure:
Chemical Name:
SCH 446132
CAS:
569351-91-3
MF:
C22H28BrN5O5
Structure:
Chemical Name:
SLU-PP-332
CAS:
303760-60-3
MF:
C18H14N2O2
Structure:
Chemical Name:
Pemigatinib
CAS:
1513857-77-6
MF:
C24H27F2N5O4
Structure:
Chemical Name:
5-Aminouridine
CAS:
2149-76-0
MF:
C9H13N3O6
Structure:
Chemical Name:
CIS-7, CIS-11-HEXADECADIENYL ACETATE
CAS:
52207-99-5
MF:
C18H32O2
Structure:
Chemical Name:
CINACALCET
CAS:
226256-56-0
MF:
C22H22F3N
Chemical Name:
Disitamab Vedotin
CAS:
2136633-23-1
Structure:
Chemical Name:
Ensitrelvir
CAS:
2647530-73-0
MF:
C22H17ClF3N9O2
Structure:
Chemical Name:
BLU-945
CAS:
2660250-10-0
MF:
C28H37FN6O3S
Structure:
Chemical Name:
Triptorelin acetate
CAS:
140194-24-7
MF:
C64H82N18O13.C2H4O2
Structure:
Chemical Name:
MonoMethylauristatin F
CAS:
745017-94-1
MF:
C39H65N5O8
Structure:
Chemical Name:
Dapagliflozin propanediol monohydrate
CAS:
960404-48-2
MF:
C24H33ClO8
Structure:
Chemical Name:
Umbralisib
CAS:
1532533-67-7
MF:
C31H24F3N5O3
Structure:
Chemical Name:
Velpatasvir
CAS:
1377049-84-7
MF:
C49H54N8O8
Structure:
Chemical Name:
Lumateperone
CAS:
313368-91-1
MF:
C24H28FN3O
Structure:
Chemical Name:
Bremelanotide Acetate
CAS:
1607799-13-2
MF:
C52H72N14O12
Chemical Name:
HGH Fragment 176-191
Structure:
Chemical Name:
GSK484
CAS:
1652591-81-5
MF:
C27H32ClN5O3
Structure:
Chemical Name:
Cibinetide
CAS:
1208243-50-8
MF:
C51H84N16O21
Structure:
Chemical Name:
Bictegravir
CAS:
1611493-60-7
MF:
C21H18F3N3O5
Structure:
Chemical Name:
SN-001
CAS:
727699-84-5
MF:
C26H21FN2O4S
Chemical Name:
DBCO-(PEG)3-VC-PAB-MMAE
MF:
C??H???N??O??
Structure:
Chemical Name:
ASTX-029
CAS:
2095719-92-7
MF:
C29H31ClFN5O5
Structure:
Chemical Name:
Enarodustat
CAS:
1262132-81-9
MF:
C17H16N4O4
Structure:
Chemical Name:
THAL-SNS-032
CAS:
2139287-33-3
MF:
C40H52N8O10S2
Structure:
Chemical Name:
B-CRYPTOXANTHIN
CAS:
472-70-8
MF:
C40H56O
Structure:
Chemical Name:
NB-598
CAS:
131060-14-5
MF:
C27H31NOS2
Structure:
Chemical Name:
Senaparib
CAS:
1401682-78-7
MF:
C24H20F2N6O3
Structure:
Chemical Name:
Beclomethasone 17-propionate
CAS:
5534-18-9
MF:
C25H33ClO6
Structure:
Chemical Name:
Ensitrelvir
CAS:
1471484-62-4
MF:
C30H33N5O5S
Structure:
Chemical Name:
Sovilnesib
CAS:
2410796-79-9
MF:
C26H34F2N6O4S
Structure:
Chemical Name:
ZLc002
CAS:
308277-46-5
MF:
C10H17NO5
Structure:
Chemical Name:
INDOMETHACIN SODIUM
CAS:
7681-54-1
MF:
C19H15ClNNaO4
Structure:
Chemical Name:
BI-2865
CAS:
2937327-93-8
MF:
C23H27N7O2S
Structure:
Chemical Name:
KP-302
CAS:
2082765-42-0
MF:
C20H23N5O2
Structure:
Chemical Name:
atpenin A5
CAS:
119509-24-9
MF:
C15H21Cl2NO5
Structure:
Chemical Name:
Eltrombopag
CAS:
496775-61-2
MF:
C25H22N4O4
Structure:
Chemical Name:
MIRODENAFIL
CAS:
862189-95-5
MF:
C26H37N5O5S
Structure:
Chemical Name:
Trolox
CAS:
53188-07-1
MF:
C14H18O4
Structure:
Chemical Name:
AT-56
CAS:
162640-98-4
MF:
C25H27N5
Structure:
Chemical Name:
Avatrombopag
CAS:
570406-98-3
MF:
C29H34Cl2N6O3S2